Serve Robotics Inc (SERV) Reports Wider Q4 Loss Than Expected
...eIPP Optimism | BETA: BETA Technologies (BETA) Reports Wider Q4 Loss But Forecasts Triple-Digit Revenue Growth for 2026 | BETA:…
...eIPP Optimism | BETA: BETA Technologies (BETA) Reports Wider Q4 Loss But Forecasts Triple-Digit Revenue Growth for 2026 | BETA:…
...| BETA: BETA Technologies Reports Wider Q4 Loss of $1.71/Share vs $0.47 Estimate, Shares Surge 12% on eIPP Optimism |…
$NERV Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system diseases, reported fourth-quarter…
$VRCA Verrica Pharmaceuticals inc (VRCA) reported a Q4 2025 adjusted loss of $0.51 per share. Top-line revenue was $5.1M. The…
$BBIO Earnings Per Share (GAAP) $-1.00 vs $-0.62 est. (wider loss, 50.6%) Revenue $154.2M estimate N/A Wider loss overshadows revenue.…
$RAPP Rapport Therapeutics Inc. (RAPP) posted a Q4 2025 GAAP loss of $0.72 per share, wider than the $0.57 per…
...ADC Therapeutics SA’s quarter follows shortly on AlphaStreet. This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed…
...(PRTH) Reports Q4 Earnings | TTMI: TTMI Shares Surge 10.1% After Beating Q4 Earnings Estimates for Fourth Consecutive Quarter |…
...BETA: BETA Technologies Reports Wider Q4 Loss of $1.71/Share vs $0.47 Estimate, Shares Surge 12% on eIPP Optimism | BETA:…
...by our editorial team. Related: IRD: Opus Genetics (IRD) Reports $0.80 Q4 Loss Despite 230% Revenue Surge to $14.2M |…